Data Sheet

MSDS

BKI-1369 [CAS 1951431-22-3]

CAS No:	1951431-22-3
Applications:	COVID-19-immunoregulation
MW:	417.51
Formula:	C₂₃H₂₇N₇O
SMILES:	NC1=C2C(N(CC3CCN(C)CC3)N=C2C4=CC=C5N=C(OCC)C=CC5=C4)=NC=N1
Purity:	99.71
Description:	BKI-1369 is a bumped kinase inhibitor (BKI). BKI-1369 increases human Ether-a-go-go-related gene (hERG)-inhibitory activity with an IC50 of 1.52 ?M. BKI-1369 reduces the parasite burden and diseases severity in the gnotobiotic pig model. BKI-1369 has been well characterized for potency, stability, metabolism, toxicity, pharmacokinetics and is potent against C. parvum in infected mice and calves[1].
Shipping Conditions:	Ship at ambient
Usage:	Research Use Only